Researcher
Inge Derdelinckx
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From5 May 2008 → Today
Projects
1 - 2 of 2
- Vaccination in individuals/patients and populations at riskFrom2 Nov 2016 → 27 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- The impact of LEDGIN-mediated retargeting of HIV integration on reactivation of latent HIVFrom1 Oct 2016 → 30 Sep 2020Funding: FWO fellowships
Publications
21 - 30 of 36
- A forgotten disease in a returning traveler from Thailand(2013)
Authors: Maarten Depypere, Jan Verhaegen, Inge Derdelinckx, Wouter Meersseman
Pages: 382 - 383 - Equivalent Dynamic Human Brain NK1-Receptor Occupancy Following Single-Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging(2012)
Authors: Koen Van Laere, Jan de Hoon, Guy Bormans, Michel Koole, Inge Derdelinckx
Pages: 243 - 250 - Fever in HIV-infected patients: less frequent but still complex(2012)
Authors: Paul De Munter, Willy Peetermans, Inge Derdelinckx, Steven Vanderschueren, Eric Van Wijngaerden
Pages: 276 - 281 - Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe(2009)
Authors: Inge Derdelinckx
Pages: 1310 - 7 - Prevalence and epidemiology of HIV type 1 drug resistance among newly diagnosed therapy-naive patients in Belgium from 2003 to 2006(2008)
Authors: Jurgen Vercauteren, Inge Derdelinckx, Koen Deforche, Marc Van Ranst, Eric Van Wijngaerden, Anne-Mieke Vandamme, Kristel Van Laethem
Pages: 355 - 362 - The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa(2008)
Authors: Inge Derdelinckx
Pages: 625 - 639 - Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial
Authors: Margaret Johnson, Princy Kumar, Jean-Michel Molina, Giuliano Rizzardini, Pedro Cahn, Markus Bickel, Josep Mallolas, Yan Zhou, Cristiana Morais, Sushma Kumar, et al.
Pages: 463 - 472 - Hiv-infectie anno 2016: van dodelijke naar chronische ziekte
Authors: Inge Derdelinckx, Paul De Munter, Willy Peetermans, Eric Van Wijngaerden
Pages: 775 - 781 - The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa (vol 13, pg 625, 2008)
Authors: Raph L Hamers, Inge Derdelinckx, Michele van Vugt, Wendy Stevens, Tobias F Rinke de Wit, Rob Chuurman
Pages: 1129 - 1129 - Pharmacokinetics of the CGRP-receptor antagonist BI44370 during and between migraine attacks
Authors: Steve Vermeersch, S Brenner, D Ferger, S Haertter, J Podhorna, Inge Derdelinckx, Jan de Hoon
Pages: 320 - 320